Skip to main content
. 2019 Jun 10;84(3):539–550. doi: 10.1007/s00280-019-03871-w

Fig. 4.

Fig. 4

Pertuzumab steady-state exposure vs. HER2 ECD concentrations. Cmin serum trough (minimum) concentration, ECD extracellular domain, HER2 human epidermal growth factor receptor 2